CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹2,265 Cr | ₹1,793 Cr | ₹1,634 Cr | ₹1,303 Cr | ₹1,242 Cr |
What is the latest Short Term Provisions ratio of CIPLA ?
| Year | Short Term Provisions |
|---|---|
| Mar2026 | ₹2,265 Cr |
| Mar2025 | ₹1,793 Cr |
| Mar2024 | ₹1,634 Cr |
| Mar2023 | ₹1,303 Cr |
| Mar2022 | ₹1,242 Cr |
How is Short Term Provisions of CIPLA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,265 Cr | 26.28 | |
| Mar2025 | ₹1,793 Cr | 9.77 | |
| Mar2024 | ₹1,634 Cr | 25.36 | |
| Mar2023 | ₹1,303 Cr | 4.96 | |
| Mar2022 | ₹1,242 Cr | - | |
Compare Short Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹108,812.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| MANKIND PHARMA | ₹104,376.0 Cr | 2.1% | 7.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -3.6% |
-5% |
-10.6% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses